U.S. markets open in 4 hours 51 minutes
  • S&P Futures

    3,998.50
    +15.50 (+0.39%)
     
  • Dow Futures

    32,561.00
    +105.00 (+0.32%)
     
  • Nasdaq Futures

    12,732.25
    +43.75 (+0.34%)
     
  • Russell 2000 Futures

    1,774.40
    +13.70 (+0.78%)
     
  • Crude Oil

    67.34
    -0.30 (-0.44%)
     
  • Gold

    1,971.50
    -11.30 (-0.57%)
     
  • Silver

    22.57
    -0.08 (-0.34%)
     
  • EUR/USD

    1.0739
    +0.0013 (+0.12%)
     
  • 10-Yr Bond

    3.4810
    0.0000 (0.00%)
     
  • Vix

    23.80
    -1.71 (-6.70%)
     
  • GBP/USD

    1.2251
    -0.0022 (-0.18%)
     
  • USD/JPY

    132.1240
    +0.8290 (+0.63%)
     
  • Bitcoin USD

    27,648.30
    -751.83 (-2.65%)
     
  • CMC Crypto 200

    600.30
    +0.63 (+0.11%)
     
  • FTSE 100

    7,485.60
    +81.75 (+1.10%)
     
  • Nikkei 225

    26,945.67
    -388.12 (-1.42%)
     

New Strong Buy Stocks for January 18th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Deutsche Telekom AG DTEGY: This integrated telecommunication services company has seen the Zacks Consensus Estimate for its current year earnings increasing 20.4% over the last 60 days.

Deutsche Telekom AG Price and Consensus

Deutsche Telekom AG Price and Consensus
Deutsche Telekom AG Price and Consensus

Deutsche Telekom AG price-consensus-chart | Deutsche Telekom AG Quote

Cyngn Inc. CYN: This autonomous vehicle technology company has seen the Zacks Consensus Estimate for its current year earnings increasing 22.2% over the last 60 days.

Cyngn Inc. Price and Consensus

Cyngn Inc. Price and Consensus
Cyngn Inc. Price and Consensus

Cyngn Inc. price-consensus-chart | Cyngn Inc. Quote

Okta, Inc. OKTA: This identity solutions company has seen the Zacks Consensus Estimate for its current year earnings increasing 62% over the last 60 days.

Okta, Inc. Price and Consensus

Okta, Inc. Price and Consensus
Okta, Inc. Price and Consensus

Okta, Inc. price-consensus-chart | Okta, Inc. Quote

Werewolf Therapeutics, Inc. HOWL: This cancer focused biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 6% over the last 60 days.

Werewolf Therapeutics, Inc. Price and Consensus

Werewolf Therapeutics, Inc. Price and Consensus
Werewolf Therapeutics, Inc. Price and Consensus

Werewolf Therapeutics, Inc. price-consensus-chart | Werewolf Therapeutics, Inc. Quote

Oncolytics Biotech Inc. ONCY: This development-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 9.4% over the last 60 days.

Oncolytics Biotech Inc. Price and Consensus

Oncolytics Biotech Inc. Price and Consensus
Oncolytics Biotech Inc. Price and Consensus

Oncolytics Biotech Inc. price-consensus-chart | Oncolytics Biotech Inc. Quote

 

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Deutsche Telekom AG (DTEGY) : Free Stock Analysis Report

Cyngn Inc. (CYN) : Free Stock Analysis Report

Oncolytics Biotech Inc. (ONCY) : Free Stock Analysis Report

Okta, Inc. (OKTA) : Free Stock Analysis Report

Werewolf Therapeutics, Inc. (HOWL) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research